x
Visit our new Mobile Website next time you access NetDania with your mobile device

HERON THERAPEUTICS INC. - COMMON STOCK

2.7100
18-19:59:57 GMT
-0.0600
-2.1661%
Today's Range
2.6950 - 2.9599
ISIN:N/A

Figures - HERON THERAPEUTICS INC. - COMMON STOCK

Open
2.7500
Close
2.7700
Year Change
59.4120
Year % Change
+59.4120%
52 Week High
3.2200
52 Week Low
0.5269
Volume
1818101
Inc. Vol
95116

News - HERON THERAPEUTICS INC. - COMMON STOCK

19-11:20 GMT
If You Invested $5,000 When Dell Went Public Again in 2018, This Is How Much You Would Have Today
Source: NASDAQ US Markets, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:20 GMT
The Ultimate Cryptocurrency to Buy With $1,000 Today
Source: NASDAQ US Markets, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:20 GMT
American Express Co. Reports Increase In Q1 Income
Source: NASDAQ US Markets, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:20 GMT
This 6.4%-Yielding Dividend Stock Remains an Extremely Safe Option for Passive Income
Source: NASDAQ US Markets, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:20 GMT
Look Under The Hood: IWS Has 13% Upside
Source: NASDAQ US Markets, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:20 GMT
PAGP Crosses Above Average Analyst Target
Source: NASDAQ US Markets, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:20 GMT
FND Crosses Above Average Analyst Target
Source: NASDAQ US Markets, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:20 GMT
BXSL Crosses Above Average Analyst Target
Source: NASDAQ US Markets, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:20 GMT
Amazon Stock Has 30% Upside, According to 1 Wall Street Analyst. Is the Stock a Buy Near Its All-Time High?
Source: NASDAQ US Markets, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:20 GMT
Huntington Bancshares Q1 24 Earnings Conference Call At 8:00 AM ET
Source: NASDAQ US Markets, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:20 GMT
Surprising Analyst 12-Month Target For ONEV
Source: NASDAQ US Markets, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:20 GMT
Peek Under The Hood: VIOO Has 18% Upside
Source: NASDAQ US Markets, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:20 GMT
Implied IUSG Analyst Target Price: $126
Source: NASDAQ US Markets, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:20 GMT
Analysts Expect VIOG To Hit $122
Source: NASDAQ US Markets, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:20 GMT
Sum Up The Parts: IJT Could Be Worth $142
Source: NASDAQ US Markets, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:19 GMT
Look Under The Hood: IWS Has 13% Upside
Source: NASDAQ Stocks, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:19 GMT
BXSL Crosses Above Average Analyst Target
Source: NASDAQ Stocks, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:19 GMT
Stock Index Futures Slip as Middle East Tensions Weigh, Netflix Shares Plunge
Source: NASDAQ Stocks, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:19 GMT
Sum Up The Parts: IJT Could Be Worth $142
Source: NASDAQ Stocks, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:19 GMT
Analysts Expect VIOG To Hit $122
Source: NASDAQ Stocks, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:19 GMT
Implied IUSG Analyst Target Price: $126
Source: NASDAQ Stocks, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:19 GMT
Peek Under The Hood: VIOO Has 18% Upside
Source: NASDAQ Stocks, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:19 GMT
Surprising Analyst 12-Month Target For ONEV
Source: NASDAQ Stocks, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:19 GMT
PAGP Crosses Above Average Analyst Target
Source: NASDAQ Stocks, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:19 GMT
FND Crosses Above Average Analyst Target
Source: NASDAQ Stocks, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:19 GMT
Lower NII & Fee Income to Hurt Truist's (TFC) Q1 Earnings
Source: NASDAQ Stocks, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:19 GMT
Badger Meter Reaches Analyst Target Price
Source: NASDAQ Stocks, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:19 GMT
Implied FNX Analyst Target Price: $120
Source: NASDAQ Stocks, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:19 GMT
5 Dividend Aristocrats Where Analysts See Capital Gains
Source: NASDAQ Stocks, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
19-11:19 GMT
Will Segmental Sales Drive General Dynamics (GD) Q1 Earnings?
Source: NASDAQ Stocks, Symbol: HERON THERAPEUTICS INC. - COMMON STOCK
Five Star Chart – Build your favorite menu, 100+ studies, for mobile and desktop
Find a Top Broker
Global
Forex
37720.58
-66.66
-0.18%
5003.23
-10.38
-0.21%
17342.25
-49.62
-0.29%
64859.00
1343
2.11%
17798.65
-37.13
-0.21%
37490.20
-287.41
-0.76%
3065.26
-8.96
-0.29%
7844.79
-34.44
-0.44%
16217.45
-115.17
-0.71%
7595.97
4.84
0.06%
22147.00
151.15
0.69%
2375.74
-4.1
-0.17%
86.20
-0.657
-0.76%
1.06516
0.00093
0.09%
154.560
-0.051
-0.03%
1.24377
0.00032
0.03%
0.64111
-0.00122
-0.19%
1.37675
-0.00032
-0.02%
164.63500
0.092
0.06%
0.85637
0.00054
0.06%
192.24000
-0.015
-0.01%
0.90899
-0.00347
-0.38%
0.96823
-0.00286
-0.29%
0.58857
-0.0016
-0.27%
106.13600
-0.02
-0.02%
Top Gainers
Name
Last
+/-
%
0.05
0.04
225.00%
1.02
0.62
155.00%
0.42
0.21
97.65%
0.80
0.32
65.02%
3.12
1.19
61.66%
0.08
0.03
59.79%
0.04
0.01
50.96%
0.08
0.02
44.06%
0.46
0.14
42.99%
6.82
2.02
42.08%
Top Losers
Name
Last
+/-
%
0.01
-0.01
-57.75%
0.03
-0.02
-47.70%
0.08
-0.07
-45.14%
5.89
-3.36
-36.32%
0.03
-0.02
-35.80%
0.06
-0.03
-35.11%
0.01
-0.01
-34.38%
0.24
-0.12
-33.32%
0.03
-0.01
-33.07%
0.10
-0.04
-32.09%
NetDania does not guarantee the accuracy of data contained on this website, nor do we guarantee that data is real-time. Data on this website may be provided from OTC market sources and market makers, and not necessarily from exchanges. The provided price data is indicative and may not be appropriate for trading or decision making purposes. NetDania does not assume any responsibility for any losses incurred from the use of the provided data.
NetDania does not endorse or promote any broker or financial service. NetDania is a pure technology provider offering its software with broker integration. Any user of NetDania software must be an existing client of one of our supported brokers. NetDania showcases NetDania technology for the purpose of demonstrating it towards brokers and other institutions looking to white label the technology on a software subscription contract. No financial services are offered, promoted or recommended. NetDania is compensated as a technology provider by its institutional clients including its integrated brokers. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation affecting it.

Persons or entities including approved brokers not belonging to the NetDania Group may advertise on the NetDania and its Group’s websites, through links, banners or otherwise. We have not taken any steps to verify the accuracy, quality or reliability of any products, information or services provided by third parties that have links on our website. We accordingly provide no warranties with regard to and disclaim responsibility for any such products, information or services and exclude all liability in this regard to the fullest extent permitted by relevant laws and regulations. If a user of the NetDania Group’s websites decides to act upon any such advertising, such user does so entirely at its own risk.

NetDania’s website may be accessed worldwide. The Information provided on its website is however only intended for use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. None of the offerings services referred to on this website are available to recipients residing in countries where the provision of such offerings would constitute a violation of mandatory applicable legislation or regulations. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation.

HIGH RISK INVESTMENT WARNING:
End-users of the NetDania software that make use of the trading integration features as direct clients of integrated brokers, should be aware of the level of risk carried by trading in financial markets. Trading foreign exchange and or other financial instruments on margin carries a high level of risk, and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to invest you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or more of your initial investment, and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading, and seek advice from your broker and or an independent financial advisor if you have any doubts. Anyone opening a live trading account needs to adhere to the laws of their local country as such laws may differ from country to country.
NetDania expressly disclaims any liability for any lost principal or profits which without limitation may arise directly or indirectly from the use of or reliance on information on our website or the use of our software with broker integration.
Copyright © 1998 -2024 NetDania Creations ApS, Holmens Kanal 7, 1060 Copenhagen K, Denmark, +4536988200, Contact NetDania by email, CVR-nr.27976670 Terms And Conditions and Privacy Policy